关于BGN在ccRCC的进展和转移中的机制的研究
Hanqing Xia1, Tianzhen He2, Xueyu Li1
1Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China.
BMC medical genomics
|March 20, 2025
概括
比格利干 (BGN) 在清细胞细胞癌 (ccRCC) 中被上调,促进其进展和转移. 抑制BGN可能为ccRCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 清细胞细胞癌 (ccRCC) 是癌最常见的亚型.
- 了解推动ccRCC进展和转移的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 调查Biglycan (BGN) 在清细胞细胞癌 (ccRCC) 的进展和转移中的作用.
- 探索BGN作为ccRCC的治疗点的潜力.
主要方法:
- 分析公共数据库,以评估ccRCC中的BGN表达及其与临床意义和免疫细胞的相关性.
- 使用实时光定量PCR对患者组织进行BGN表达的验证.
- 在ccRCC细胞系 (786-0和Caki-1) 中使用BGN淘汰的体外研究,以评估对增殖,迁移和入侵的影响.
- 生物信息分析 (GO-KEGG,GSEA) 以确定相关的信号通路,包括MAPK.
主要成果:
- 与正常组织相比,ccRCC组织中的biglycan (BGN) 表达显著上调.
- 高BGN表达与ccRCC进展和免疫细胞透增加相关.
- 在体外中,BGN敲除抑制了ccRCC细胞的增殖,迁移和入侵.
- 观察到的BGN效应可能通过MAPK信号通路进行介导.
结论:
- 比格利坎 (BGN) 在ccRCC的进展和转移中发挥着重要作用.
- BGN可能通过MAPK信号通路发挥其作用.
- 在ccRCC治疗中,BGN是一个有前途的治疗点.
更多相关视频
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
8.8K
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
10.7K
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
